ASP Isotopes Inc.

ASP Isotopes Inc. is an advanced materials company specializing in the development and production of enriched isotopes through proprietary technologies, most notably the Aerodynamic Separation Process. Its core mission is to supply high-value isotopes integral to several critical sectors, including nuclear medicine and therapeutics, green energy generation, and quantum computing. The company operates enrichment facilities in South Africa, initially focusing on commercial-scale production for the nuclear medicine market, with applications extending to isotopes needed in next-generation quantum computing and clean energy solutions. Notably, ASP Isotopes Inc. is active in the development of isotopes such as Silicon-28, Molybdenum-100, Zinc-68, Lithium-6, and Uranium-235, each essential for advanced medical diagnostics, innovative therapies, and emerging low-carbon energy technologies. By leveraging its modular, cost-effective, and environmentally conscious processes, the company seeks to provide commercial and operational advantages across a spectrum of highly specialized and rapidly evolving industries, cementing its significance as a strategic supplier in the global isotope marketplace.